Botox maker to pay $600M to resolve investigation
by on Sep.02, 2010, under Health and Fitness
Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
View full post on Yahoo! Health News
